FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and pharmacology and can be used for studying the toxic effect on the cardiac conduction system in pre-clinical study of new cardioprotective agents, studying mechanisms of their action and developing new methods of treatment. A method for modeling toxic cardiac involvement in rats involves toxic cardiac involvement in animals by daily at least 2 weeks of administration of a complex of antituberculous preparations moxifloxacin, bedaquiline, linezolid, protionamide and capreomycin, rat females aged 10–12 months and weighing 330–350 g used for modeling.
EFFECT: invention provides good reproducibility, absence of lethal outcome of experimental animals and short period of development of pathological condition.
5 cl, 3 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING OF COMBINED DRUG-INDUCED HEART AND KIDNEYS INJURY IN RATS | 2019 |
|
RU2726927C1 |
METHOD FOR MODELING ACQUIRED LONG QT INTERVAL SYNDROME USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2794488C1 |
METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF ARRHYTHMIAS IN ADOLESCENTS WITH RESPIRATORY TUBERCULOSIS | 2023 |
|
RU2814004C1 |
METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
METHOD FOR CORRECTION OF ARRHYTHMIA IN OLDER CHILDREN SUFFERING RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE MTB RECEIVING BEDAQUILINE IN CHEMOTHERAPY MODES | 2023 |
|
RU2826083C1 |
USE OF NANOPHOSPHOLIPID COMPOSITION OF RIFAMPICINE TOGETHER WITH PROTIONAMIDE OR ITS NANOPHOSPHOLIPID FORM IN TREATMENT OF TUBERCULOSIS | 2014 |
|
RU2595881C2 |
METHOD FOR MONITORING THE CARDIOTOXIC EFFECT OF BEDAQUILINE IN OLDER CHILDREN AND ADOLESCENTS WITH RESPIRATORY TUBERCULOSIS | 2022 |
|
RU2783061C1 |
METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
Authors
Dates
2020-07-16—Published
2019-12-18—Filed